|
|
|
|
|
|
|
|
|
|
ROBERT L. EHRLICH, JR., Governor H.B. 1287
LAW TO BE HELD CONFIDENTIAL, IS FILED IN A MANNER THAT, EXCEPT AS
OTHERWISE PROVIDED IN § 21-2A-06 OF THIS SUBTITLE, DOES NOT DISCLOSE THE
IDENTITY OF THE PERSON PROTECTED.
(E) PRESCRIPTION MONITORING DATA SHALL BE DESTROYED AFTER 2 YEARS,
UNLESS A LAW ENFORCEMENT AGENCY OR A HEALTH OCCUPATIONS BOARD HAS
SUBMITTED A WRITTEN REQUEST TO THE DEPARTMENT FOR RETENTION OF
SPECIFIC INFORMATION.
21-2A-03.
(A) THERE IS AN ADVISORY BOARD ON PRESCRIPTION DRUG MONITORING IN
THE DEPARTMENT.
(B) THE BOARD CONSISTS OF THE FOLLOWING 15 21 MEMBERS:
(1) THE ATTORNEY GENERAL, OR THE ATTORNEY GENERAL'S DESIGNEE;
(2) THE SECRETARY, OR THE SECRETARY'S DESIGNEE;
(3) THE PRESIDENT OF THE MARYLAND BOARD OF PHARMACY, OR THE
PRESIDENT'S DESIGNEE;
(4) THE CHAIRMAN OF THE MARYLAND BOARD OF PHYSICIANS, OR THE
CHAIRMAN'S DESIGNEE;
(5) THE PRESIDENT OF THE MARYLAND BOARD OF NURSING, OR THE
PRESIDENT'S DESIGNEE;
(5) (6) THE CHAIRMAN OF THE MARYLAND HEALTH CARE
COMMISSION, OR THE CHAIRMAN'S DESIGNEE;
(6) (7) TWO FOUR PHYSICIANS AND ONE NURSE PRACTITIONER WITH
EXPERTISE IN PHYSICAL MEDICINE AND REHABILITATION AREAS OF PRACTICE THAT
INVOLVE PAIN MANAGEMENT AND SUBSTANCE ABUSE AND ADDICTION TREATMENT,
APPOINTED BY THE SECRETARY AFTER CONSULTATION WITH:
(I) THE MEDICAL AND CHIRURGICAL FACULTY OF MARYLAND,
THE MARYLAND STATE MEDICAL SOCIETY, THE MARYLAND PHYSICAL MEDICINE
AND REHABILITATION SOCIETY, AND THE MARYLAND SOCIETY OF
ANESTHESIOLOGISTS WITH RESPECT TO THE PHYSICIAN APPOINTMENTS; AND
(II) THE MARYLAND NURSES ASSOCIATION WITH RESPECT TO THE
NURSE PRACTITIONER APPOINTMENT;
(7) (8) TWO FOUR PHARMACISTS WHO REPRESENT THE PERSPECTIVE
OF INDEPENDENT AND CHAIN PHARMACIES AND PHARMACISTS, APPOINTED BY THE
SECRETARY AFTER CONSULTATION WITH THE MARYLAND PHARMACISTS
ASSOCIATION, THE MARYLAND ASSOCIATION OF CHAIN DRUG STORES, EPIC
PHARMACIES, AND ANY OTHER APPROPRIATE ORGANIZATION:
(I) THREE OF WHOM REPRESENT THE PERSPECTIVE OF
INDEPENDENT AND CHAIN PHARMACIES AND PHARMACISTS; AND
- 3825 -
|
|
|
|
|
|
|
|
|
|
|
|
|